Corporate Finance Equity Deals M&A Deals Old Articles
Is there more than tax-inversion to AbbVie-Shire $54bn deal?
AbbVie Inc., Market Cap (as of 19/09/2014): $94.63bn Shire plc., Market Cap (as of 19/09/2014): £31.12bn In its attempt to become one of the global leaders in the rare diseases market, AbbVie successfully got the approval from Shire’s board of directors for its $54bn acquisition. This approval came after two Read more…